Med-Chemist : "Quintessential Medicinal Chemistry"
Showing posts with label
Oral Suspension
.
Show all posts
Showing posts with label
Oral Suspension
.
Show all posts
Friday, October 31, 2025
FDA Approves Subvenite (lamotrigine) Oral Suspension for Epilepsy and Bipolar Disorder
›
OWP Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) approval of Subvenite Oral Suspension, the first and only lamotr...
Wednesday, June 25, 2025
FDA Approves Arbli (losartan potassium) Oral Suspension as the First Ready-to-Use Oral Liquid Losartan in the U.S.
›
In continuation of my update on losartan Scienture Holdings, Inc. announced the U.S. Food and Drug Administration (FDA) approval of SCN-1...
Tuesday, September 24, 2024
FDA Approves Myhibbin (mycophenolate mofetil) Oral Suspension for Prophylaxis of Organ Rejection
›
Azurity Pharmaceuticals, a pharmaceutical company focused on developing innovative dose forms and formulations of products to serve the need...
›
Home
View web version
